,title,source,link,date
1,Mangalam Drugs & Organics Second Quarter 2024 Earnings: ₹2.25 loss per share (vs ₹1.41 profit in 2Q 2023),Simply Wall St,news.google.com/articles/CBMipQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1tYW5nYWxhbS9tYW5nYWxhbS1kcnVncy1vcmdhbmljcy1zaGFyZXMvbmV3cy9tYW5nYWxhbS1kcnVncy1vcmdhbmljcy1zZWNvbmQtcXVhcnRlci0yMDI0LWVhcm5pbmdzLTIyNS1sb3PSAakBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy9pbi9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uc2UtbWFuZ2FsYW0vbWFuZ2FsYW0tZHJ1Z3Mtb3JnYW5pY3Mtc2hhcmVzL25ld3MvbWFuZ2FsYW0tZHJ1Z3Mtb3JnYW5pY3Mtc2Vjb25kLXF1YXJ0ZXItMjAyNC1lYXJuaW5ncy0yMjUtbG9zL2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-14
